CLAUDIA

Mirasol Announces the Launch of Partner-Funded Drill Program at the Claudia Gold-Silver Project in Argentina

Retrieved on: 
Tuesday, October 3, 2023
LSE, CVSA, South Tyrol Option Agreement, Rio, Option, Deseado Massif, Vanguardia, AngloGold Ashanti, MRZ, Cerro Vanguardia Mine, OTC, Erosion, News, Mining, Homenaje

(7.5%), has initiated a drill program at the Claudia Gold-Silver Project (“Claudia”), located directly south of the CVSA Gold-Silver Mine in the province of Santa Cruz, Argentina.

Key Points: 
  • (7.5%), has initiated a drill program at the Claudia Gold-Silver Project (“Claudia”), located directly south of the CVSA Gold-Silver Mine in the province of Santa Cruz, Argentina.
  • Under an Option Agreement, CVSA has the right to acquire a 100 percent interest in Claudia by completing 12,500 meters of diamond drilling within four years.
  • If the Option is exercised, Mirasol will retain a 2% Net Smelter Royalty on future production from the Claudia Project ( news release May 23, 2023 ).
  • Mirasol today also announces that the option agreement on the Homenaje Gold-Silver Project in Argentina (“Homenaje”) with Patagonia Gold Corp. (“Patagonia”) has been terminated.

Mirasol Signs Option Agreement with AngloGold Ashanti’s Cerro Vanguardia SA Mine to Advance the Claudia Gold-Silver Project in Argentina

Retrieved on: 
Tuesday, May 23, 2023
Exercise, Agreement, LSE, CVSA, Completeness, Rio, Deseado Massif, Vanguardia, AngloGold Ashanti, DDH, RC, MRZ, Cerro Vanguardia Mine, JV, OTC, Erosion, MMI, Mining, Road

(7.5%) for the exploration of Mirasol’s Claudia Gold-Silver Project (“Claudia”), located directly south of the CVSA Gold-Silver Mine in the province of Santa Cruz, Argentina.

Key Points: 
  • (7.5%) for the exploration of Mirasol’s Claudia Gold-Silver Project (“Claudia”), located directly south of the CVSA Gold-Silver Mine in the province of Santa Cruz, Argentina.
  • “The Agreement with CVSA demonstrates the potential for continued discovery and resource development at Claudia,” Mirasol’s President Tim Heenan stated.
  • Five distinct prospective vein trends have been identified at Claudia including the Curahue Vein Field and the Rio Seco Prospect.
  • Claudia also hosts two shallow paleo-surface expressions of “sinter fields” at both Calandria and Rio Seco.

Coave Therapeutics Strengthens Board of Directors

Retrieved on: 
Thursday, October 20, 2022
National Institute, LinkedIn, Master of Science, Therapy, List of life sciences, Growth, General manager, Science, Neurodegeneration, Medical research, Biotechnology, Takeda Pharmaceutical Company, RNA interference, INSEAD, MBA, Research, The Advisory Board Company, Bachelor of Science, Senior, Eye, University, Company, Doctor of Philosophy, AAV, Industry, INSERM, Board, CEO, Portfolio strategy, Safety, ATyr Pharma, Management, Molecular biology, Consulate General of Israel to the Pacific Northwest Region, Board of directors, Director, International Management Institute, New Delhi, Genzyme, Central nervous system, Pharmaceutical industry, Vaccine, University of Paris, Astellas Pharma, Physics

PARIS, Oct. 20, 2022 /PRNewswire/ -- Coave Therapeutics ('Coave'), a biotech company leading the transition of genetic medicine from (ultra) rare to prevalent conditions in neurodegenerative diseases, today announces Frederic Chereau as Chairman of the Board and the appointment of Dr Claudia Mitchell, PhD, MBA to the Company's Board of Directors as an independent non-executive director.

Key Points: 
  • PARIS, Oct. 20, 2022 /PRNewswire/ -- Coave Therapeutics ('Coave'), a biotech company leading the transition of genetic medicine from (ultra) rare to prevalent conditions in neurodegenerative diseases, today announces Frederic Chereau as Chairman of the Board and the appointment of Dr Claudia Mitchell, PhD, MBA to the Company's Board of Directors as an independent non-executive director.
  • Dr Claudia Mitchell added: "I am delighted to be joining Coave's Board during this exciting period of growth for the Company.
  • The Coave Board of Directors is as follows:
    At Coave Therapeutics, we are leading the transition of genetic medicine from (ultra) rare to prevalent conditions, with an initial focus on neurodegenerative diseases.
  • Headquartered in Paris, France, Coave Therapeutics is backed by leading international life sciences investors.

Coave Therapeutics Strengthens Board of Directors

Retrieved on: 
Thursday, October 20, 2022
National Institute, LinkedIn, Master of Science, Therapy, List of life sciences, Growth, General manager, Science, Neurodegeneration, Medical research, Biotechnology, Takeda Pharmaceutical Company, RNA interference, INSEAD, MBA, Research, The Advisory Board Company, Bachelor of Science, Senior, Eye, University, Company, Doctor of Philosophy, AAV, Industry, INSERM, Board, CEO, Portfolio strategy, Safety, ATyr Pharma, Management, Molecular biology, Consulate General of Israel to the Pacific Northwest Region, Board of directors, Director, International Management Institute, New Delhi, Genzyme, Central nervous system, Pharmaceutical industry, Vaccine, University of Paris, Astellas Pharma, Physics

PARIS, Oct. 20, 2022 /PRNewswire/ -- Coave Therapeutics ('Coave'), a biotech company leading the transition of genetic medicine from (ultra) rare to prevalent conditions in neurodegenerative diseases, today announces Frederic Chereau as Chairman of the Board and the appointment of Dr Claudia Mitchell, PhD, MBA to the Company's Board of Directors as an independent non-executive director.

Key Points: 
  • PARIS, Oct. 20, 2022 /PRNewswire/ -- Coave Therapeutics ('Coave'), a biotech company leading the transition of genetic medicine from (ultra) rare to prevalent conditions in neurodegenerative diseases, today announces Frederic Chereau as Chairman of the Board and the appointment of Dr Claudia Mitchell, PhD, MBA to the Company's Board of Directors as an independent non-executive director.
  • Dr Claudia Mitchell added: "I am delighted to be joining Coave's Board during this exciting period of growth for the Company.
  • The Coave Board of Directors is as follows:
    At Coave Therapeutics, we are leading the transition of genetic medicine from (ultra) rare to prevalent conditions, with an initial focus on neurodegenerative diseases.
  • Headquartered in Paris, France, Coave Therapeutics is backed by leading international life sciences investors.

Windsor Fashions Launches Festival Campaign With Influencers Claudia Graziano, Josi Pellicano and Pia Shah

Retrieved on: 
Wednesday, March 23, 2022
Jewellery, Chic, Festival, Josi, Friends, Clothing, Travel, GLOBE, Beauty, Instagram, Collection, Fashion

The Festival Edit offers everything needed to elevate your festival experience and make you Instagram ready.

Key Points: 
  • The Festival Edit offers everything needed to elevate your festival experience and make you Instagram ready.
  • Whether your style is boho, glam or rock, Windsor Fashions is the ultimate destination for a variety of looks to dance all day and party all night in this festival season.
  • When putting together the collection, Claudia, Josi and Pia wanted to feature an assortment of festival dresses, tops, accessories and more that represent a variety of styles that can be worn during a music-filled weekend.
  • Their collaboration with Windsor provides an assortment of items that can suit any style and complete every 2022 festival outfit .

Clave Hires 2 Senior Executives to Round Out its Leadership Team

Retrieved on: 
Tuesday, February 8, 2022
Citadel, Latham & Watkins, Growth, Chairperson, ALS, Awareness, Science and technology in Asia, Industry, Marketing, World, CMO, Blockchain, Technology, Citizen Effect, CEO, Latham, Management, Clave

GREENWICH, Conn., Feb. 8, 2022 /PRNewswire/ -- Clave, a leading fintech consumer lending company inLatin America, today announces the appointment of two senior executives to its leadership team.

Key Points: 
  • GREENWICH, Conn., Feb. 8, 2022 /PRNewswire/ -- Clave, a leading fintech consumer lending company inLatin America, today announces the appointment of two senior executives to its leadership team.
  • Neel Parekh joins Clave as Chief Strategy Officer with 15+ years of experience in finance, investing in fintech, consumer and technology companies.
  • Claudia Nieves joins Clave as Chief Marketing Officer with 15+ years of experience in marketing and consumer data analytics.
  • Clave's additions to its leadership team come on the heels of Clave's expansion into Colombia.

Table XI Matures Approach to Governance With Announcement of Advisory Board

Retrieved on: 
Tuesday, January 25, 2022
XI, Growth, Golden, Organization, DEI, Technology, Leadership, Salesforce, Shailesh J. Mehta School of Management, Goal, IOT, Engineering, GLOBE, Acquisition, CEO, Management, Khalilah, Parallax

CHICAGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Table XI , a strategy and product innovation firm, today announced the appointment of its five-person advisory board.

Key Points: 
  • CHICAGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Table XI , a strategy and product innovation firm, today announced the appointment of its five-person advisory board.
  • By recognizing product innovation as a people-first process, the board will serve Table XI leadership, clients, and employees as they uncover user needs and enable digital experiences to address them.
  • Representing over a century of combined leadership experience in technology, innovation, organizational change, and diversity and inclusion, advisory board members were named after a rigorous selection process by Table XI leadership and its ownership group.
  • Khalilah will help Table XI create an engaging culture that brings the best out of its talent.

National Geographic Society Strengthens Board of Trustees With Appointment of Five New Members

Retrieved on: 
Wednesday, January 12, 2022

"On behalf of the entire board, I am delighted to welcome these five distinguished leaders to the National Geographic Society's board of trustees," said board chair Jean Case.

Key Points: 
  • "On behalf of the entire board, I am delighted to welcome these five distinguished leaders to the National Geographic Society's board of trustees," said board chair Jean Case.
  • The organization also created the new role of Explorer Trustee, a position to be held by a National Geographic Explorer.
  • Kahumbu has been part of the National Geographic community for 12 years; in June 2021 she was named the Rolex National Geographic Explorer of the Year.
  • Kahumbu will become the first National Geographic Explorer to join the Society's board of trustees.

Manatt Continues Growth of National Health Care Group With Arrival of Industry Trailblazers

Retrieved on: 
Wednesday, January 12, 2022
General Health, Consulting, Health, Professional Services, Legal, Linda, Research, Technology, Patient, Connecticut College, University, Manatt, Phelps & Phillips, COVID-19, COO, Fortune 500, Safety, CEO, Company, LLP, University of California Television, Government, Feinberg School of Medicine, Mental health, New York State Department of Health, Leadership, Health policy, Health, School, History, Consultant, Purdue University, Diagnosis, Association, Lawyer, University School, Physician, Policy, Management, Pharmaceutical industry, Medicine, Medicaid

Christina and Claudias health care consulting and business experience is an exciting addition to our team, and they will be invaluable resources for our health care clients across all corners of the industry.

Key Points: 
  • Christina and Claudias health care consulting and business experience is an exciting addition to our team, and they will be invaluable resources for our health care clients across all corners of the industry.
  • As one of New Yorks most notable health care leaders, Dr. Jenkins has proven experience in health system redesign and growth strategies, health care technology assessments, large-scale change management and multistakeholder collaboration, care model development, and clinical value improvement, and she works closely with health care leaders across provider, payer and venture-backed health care organizations.
  • Page added: I have worked alongside Manatt Health for years and could not be more delighted to join this remarkable and diverse group of health care professionals.
  • The group also recently announced the expansion and rebrand of its premium health care information service, Manatt on Health: Insights You Trust , which distills the latest legal, policy and market-based developments on the issues that matter most to health industry stakeholders.

Mission Wealth Names Three New Partners to Firm in 2022

Retrieved on: 
Thursday, January 6, 2022
Licensure, Intention, Goal, RIA, Investment Management Consultants Association, Philosophy, Travel, Financial plan, Heart, Cornell University, CDFA, University of North Carolina at Greensboro, Culture, Skiing, Chapel Hill, Board, Risk management, Consultant, College, Collection, AIF, Vienna Business School, University, Swimming, Director, Ownership, Hospital, CEO, Investment management, Industry, Family, Accredited Investment Fiduciary, Tennis, University of California, Berkeley, CIMA, MBA, Partnership, Golf, CO, List, Solution, CFP, Management, Financial services, Financial adviser, Science, Economics

SANTA BARBARA, Calif., Jan. 6, 2022 /PRNewswire-PRWeb/ --Mission Wealth is pleased to announce the addition of three new partners to the firm: Amanda Thomas, Claudia Arnold-Sawaf, and Rick D. Gonzalez.

Key Points: 
  • SANTA BARBARA, Calif., Jan. 6, 2022 /PRNewswire-PRWeb/ --Mission Wealth is pleased to announce the addition of three new partners to the firm: Amanda Thomas, Claudia Arnold-Sawaf, and Rick D. Gonzalez.
  • "We are excited to welcome three new partners to the firm, bringing our grand total to nineteen and helping us ensure that we have expanded leadership to steward the firm for many years to come," said Matthew Adams , CEO at Mission Wealth.
  • As an Advisor at Mission Wealth, Claudia serves private wealth clients and private foundations.
  • Advisory services are only offered to clients or prospective clients where Mission Wealth and its representatives are properly licensed or exempt from licensure.